ETHYL 6-CYCLOPROPYLPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLATE, 95.0%, 500mg

6-Fluoropyrazolo[1,5-a]pyridine-3-carboxylic acid, 95.0%, 100mg

(R)-5,6-Dimethoxy-2,3-dihydro-1H-inden-1-amine hydrochloride, 95%, 250mg

2,4,6-Trifluorophenol, 97.0%, 1g

1-Butyl-3-methylimidazolium Tetrafluoroborate>98.0%(HPLC)(N)25g

Benzyl 3-(N-cyclopropyl-N-((1S,4S)-4-(ethoxycarbonyl)cyclohexyl)sulfamoyl)benzoate, 98%, 100mg

3-Dimethylamino-2,2-dimethyl-1-propanol>97.0%(GC)(T)500mL

Elettrodo combinato pH InLab® Surface

3,6-Dibromo-2,7-dihydroxynaphthalene>98.0%(GC)5g

5-(4-Chlorophenyl)thiazol-2-amine, 95.0%, 25g

Diethyl (S)-(2-((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoethyl)phosphonate, 98%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((2,2,10,10-tetramethyl-4,8-dioxo-3,9-dioxa-5,7-diazaundecan-6-ylidene)amino)pentanoic acid, 97%, 5g

4-Bromo-2-propoxybenzaldehyde, 95.0%, 5g